Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices

Through expert, case-based discussion, Jame Abraham, MD, and Kelley Mayden, MSN, FNP, AOCNP®, presented existing and emerging data for current and investigational therapies for HER2-positive breast cancer and their associated adverse events, in addition to best practices for managing central nervous...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraham, Jame, Mayden, Kelley D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857326/
https://www.ncbi.nlm.nih.gov/pubmed/33598324
http://dx.doi.org/10.6004/jadpro.2020.11.3.11
_version_ 1783646426184548352
author Abraham, Jame
Mayden, Kelley D.
author_facet Abraham, Jame
Mayden, Kelley D.
author_sort Abraham, Jame
collection PubMed
description Through expert, case-based discussion, Jame Abraham, MD, and Kelley Mayden, MSN, FNP, AOCNP®, presented existing and emerging data for current and investigational therapies for HER2-positive breast cancer and their associated adverse events, in addition to best practices for managing central nervous system metastases.
format Online
Article
Text
id pubmed-7857326
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-78573262021-02-16 Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices Abraham, Jame Mayden, Kelley D. J Adv Pract Oncol Meeting Reports Through expert, case-based discussion, Jame Abraham, MD, and Kelley Mayden, MSN, FNP, AOCNP®, presented existing and emerging data for current and investigational therapies for HER2-positive breast cancer and their associated adverse events, in addition to best practices for managing central nervous system metastases. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857326/ /pubmed/33598324 http://dx.doi.org/10.6004/jadpro.2020.11.3.11 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Abraham, Jame
Mayden, Kelley D.
Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices
title Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices
title_full Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices
title_fullStr Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices
title_full_unstemmed Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices
title_short Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices
title_sort improving outcomes in her2-positive breast cancer: analysis and application of evolving data and best practices
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857326/
https://www.ncbi.nlm.nih.gov/pubmed/33598324
http://dx.doi.org/10.6004/jadpro.2020.11.3.11
work_keys_str_mv AT abrahamjame improvingoutcomesinher2positivebreastcanceranalysisandapplicationofevolvingdataandbestpractices
AT maydenkelleyd improvingoutcomesinher2positivebreastcanceranalysisandapplicationofevolvingdataandbestpractices

Ejemplares similares